Selective targeting of NRF2-high pancreatic ductal adenocarcinoma with an NQO1-activatable prodrug

Journal:

Proceedings of the National Academy of Sciences of the United States of America

Published:

2026-01-21

DOI:

10.1073/pnas.2511733123

Affiliations:

12

Authors:

22

Go to article

Institutions	Authors	Share
University of California, San Diego (UC San Diego), United States of America (USA)	7.000000	0.32
UC San Diego Health Sciences, United States of America (USA)	4.500000	0.20
NYU Langone Health, United States of America (USA)	2.000000	0.09
UCLA Health, United States of America (USA)	2.000000	0.09
State Key Laboratory of Natural Medicines (SKLNM), CPU, China	2.000000	0.09
Moores Cancer Center, United States of America (USA)	1.500000	0.07
Zhongda Hospital, SEU, China	1.000000	0.05
The First Affiliated Hospital, Zhejiang University School of Medicine, China	1.000000	0.05
Drum Tower Hospital, China	1.000000	0.05

Interested in Oncology and Carcinogenesis?